Gene editing in 2026: a crash course
A sourced crash course on CRISPR, base and prime editing, delivery, approved therapies like Casgevy and where gene editing stands in October 2026.
Gene editing and gene therapy
CRISPR, base and prime editing, and the therapies that rewrite DNA to treat disease.
Gene editing tracker: approvals, trials and setbacks
A dated, sourced timeline of gene-editing milestones: Casgevy approvals, in vivo CRISPR trials, base and prime editing, FDA actions and safety events.
Base editing
Casgevy (exa-cel)
CRISPR-Cas9
CRISPR Therapeutics
Intellia Therapeutics
Lipid nanoparticle delivery for gene editing
Personalized (bespoke) gene editing
Prime editing
Who can get gene-editing cures? The access and cost debate
How safe is in vivo gene editing? The 2026 debate
How CRISPR gene editing works: cutting, base and prime editing
How gene therapies are delivered: ex vivo, viral vectors and LNPs